142 related articles for article (PubMed ID: 18698541)
21. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
[TBL] [Abstract][Full Text] [Related]
23. [A failed improvement in pulmonary function and exercise capacity with carvedilol in congestive heart failure despite an excellent effect on left ventricular function].
Guazzi M; Pontone G; Trevisi N; Lomanto M; Matturri M; Agostoni P
Cardiologia; 1998 Feb; 43(2):181-7. PubMed ID: 9557374
[TBL] [Abstract][Full Text] [Related]
24. [Preliminary study on the effect of carvedilol on children with primary endocardial fibroelastosis].
Li R; Yi QJ; Qian YR; Liu XY; Zhong JR; Bai YH; Mi Q; Li XL
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):684-7. PubMed ID: 19099859
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of carvedilol and metoprolol on exercise ventilatory efficiency in patients with congestive heart failure.
Kataoka M; Satoh T; Yoshikawa T; Nakamura I; Kohno T; Yoshizawa A; Anzai T; Ogawa S
Circ J; 2008 Mar; 72(3):358-63. PubMed ID: 18296829
[TBL] [Abstract][Full Text] [Related]
26. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
[TBL] [Abstract][Full Text] [Related]
27. Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure.
Palazzuoli A; Carrera A; Calabria P; Puccetti L; Pastrorelli M; Pasqui AL; Auteri A; Bruni F
Am Heart J; 2004 Jan; 147(1):E2. PubMed ID: 14691440
[TBL] [Abstract][Full Text] [Related]
28. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
29. N-terminal prohormone brain natriuretic peptide plasma levels in heart failure are affected both directly and indirectly by carvedilol.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
Angiology; 2008; 59(3):323-8. PubMed ID: 18388105
[TBL] [Abstract][Full Text] [Related]
30. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol.
Guazzi M; Agostoni P; Matturri M; Pontone G; Guazzi MD
Am Heart J; 1999 Sep; 138(3 Pt 1):460-7. PubMed ID: 10467196
[TBL] [Abstract][Full Text] [Related]
32. Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure.
Castro P; Vukasovic JL; Chiong M; Díaz-Araya G; Alcaino H; Copaja M; Valenzuela R; Greig D; Pérez O; Corbalan R; Lavandero S
Eur J Heart Fail; 2005 Oct; 7(6):1033-9. PubMed ID: 16227141
[TBL] [Abstract][Full Text] [Related]
33. Does atrial fibrillation in elderly patients with chronic heart failure limit the efficacy of carvedilol? Suggestions from an observational study.
Opasich C; De Feo S; Cioffi G; Pulignano G; Del Sindaco D; Tarantini L; Gualco A; Patrignani A
Ital Heart J; 2005 Apr; 6(4):323-7. PubMed ID: 15902931
[TBL] [Abstract][Full Text] [Related]
34. Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study.
Bagriy AE; Schukina EV; Samoilova OV; Pricolota OA; Malovichko SI; Pricolota AV; Bagriy EA
Adv Ther; 2015 Feb; 32(2):108-19. PubMed ID: 25700807
[TBL] [Abstract][Full Text] [Related]
35. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
[TBL] [Abstract][Full Text] [Related]
36. Serum biomarkers and clinical outcomes in heart failure patients treated de novo with carvedilol.
Nessler J; Nessler B; Golebiowska-Wiatrak R; Palka I; Gackowski A; Kitlinski M; Melander O; Fedorowski A
Cardiol J; 2013; 20(2):144-51. PubMed ID: 23558872
[TBL] [Abstract][Full Text] [Related]
37. Effect of carvedilol on exercise tolerance in patients with chronic heart failure and a restrictive left ventricular filling pattern.
Al-Nasser F; Yousufuddin M; Al-Nozha F; Anker SD; Coats AJ; Piepoli MF; Ponikowski PP
Am J Cardiol; 2003 May; 91(10):1281-3. PubMed ID: 12745124
[No Abstract] [Full Text] [Related]
38. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT
J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
[TBL] [Abstract][Full Text] [Related]
39. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
[TBL] [Abstract][Full Text] [Related]
40. Sudden cardiac death risk factors in patients with heart failure treated with carvedilol.
Nessler J; Nessler B; Kitliński M; Libionka A; Kubinyi A; Konduracka E; Piwowarska W
Kardiol Pol; 2007 Dec; 65(12):1417-22; discussion 1423-4. PubMed ID: 18181053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
